Genmab A (GMAB) Total Current Liabilities (2019 - 2026)

Genmab A's (GMAB) quarterly Total Current Liabilities came in at $1.2 billion in Q1 2026, down 17.45% on a QoQ basis from $1.4 billion in Q4 2025.

Genmab A (GMAB) Total Current Liabilities (2019 - 2026) Analysis & Trends

Genmab A (GMAB) has 6 years of Total Current Liabilities data on file, last reported at $1.2 billion in Q1 2026.

  • Quarterly Total Current Liabilities changed N/A year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (changed N/A YoY) and the FY2025 annual result came in at $1.4 billion, up 91.8% from the prior year.
  • Total Current Liabilities declined to $1.2 billion in Q1 2026, from $1.4 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $1.4 billion in Q4 2025 to a low of $368.0 million in Q4 2023.
  • A 4-year average of $847.8 million and a median of $742.5 million in 2024 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2024 — Total Current Liabilities surged 102.17% — and 2025, when it soared 91.8%.
  • Tracing GMAB's Total Current Liabilities over 4 years: stood at $368.0 million in 2023, then surged by 102.17% to $744.0 million in 2024, then soared by 91.8% to $1.4 billion in 2025, then decreased by 17.45% to $1.2 billion in 2026.
  • The last three Total Current Liabilities figures came in at $1.2 billion (Q1 2026), $1.4 billion (Q4 2025), and $741.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.58 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 354.06 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 2.12 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 4.22 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 630.93 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.51 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 438.74 Mn
10 Genmab A 2.05 Bn 548.77 Mn 1.07 Bn 1.14 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.14 Bn
Mar 31, 2026 1.18 Bn
Dec 31, 2025 1.43 Bn
Sep 30, 2025 741.00 Mn
Jun 30, 2025 629.00 Mn
Dec 31, 2024 744.00 Mn
Dec 31, 2023 368.00 Mn
Sep 30, 2020 2,258.00
Dec 31, 2019 938.00
Sep 30, 2019 654.77 Mn